BNGO

SEC source: 0001411690-25-000015 · wk-form4_1740009387.xml · nonDerivative · entry 1

Adamchak Mark · CIK 0002036536 · Principal Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 270

F1 · kind: The reporting person is reporting the withholding by the Issuer of an aggregate of 4 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.

F1 · shares: The reporting person is reporting the withholding by the Issuer of an aggregate of 4 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.

F2 · balance_after: On January 24, 2025, the common stock of Bionano Genomics, Inc. split 1-for-60, resulting in the reporting person's ownership of 16,197 less shares of common stock.

SEC source: 0001411690-24-000057 · wk-form4_1727910827.xml · derivative · entry 1

Adamchak Mark · CIK 0002036536 · Principal Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,500

Underlying: Common Stock · 17,500 shares

Expires 2034-09-30

F1 · derivative.exercise_date: 100% of the shares subject to the option vest on the one-year anniversary of the grant date.

SEC source: 0001411690-24-000053 · wk-form4_1726258505.xml · nonDerivative · entry 1

OLDAKOWSKI MARK · CIK 0001745566 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,283

F1 · kind: The reporting person is reporting the withholding by the Issuer an aggregate of 3,568 shares of common stock that vested on September 11, 2024, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.

F1 · shares: The reporting person is reporting the withholding by the Issuer an aggregate of 3,568 shares of common stock that vested on September 11, 2024, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.

F2 · balance_after: Includes 153 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan on June 10, 2024.

SEC source: 0001411690-24-000052 · wk-form4_1726258263.xml · nonDerivative · entry 1

Chaubey Alka · CIK 0001821605 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,323

F1 · kind: The reporting person is reporting the withholding by the Issuer an aggregate of 3,075 shares of common stock that vested on September 11, 2024, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.

F1 · shares: The reporting person is reporting the withholding by the Issuer an aggregate of 3,075 shares of common stock that vested on September 11, 2024, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.

F2 · balance_after: Includes 153 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan on June 10, 2024.

SEC source: 0001411690-24-000033 · wk-form4_1718914954.xml · derivative · entry 1

Wong Vincent Jung-Fai · CIK 0001898723 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-06-18

F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan).

SEC source: 0001411690-24-000030 · wk-form4_1718914921.xml · derivative · entry 1

Linney Yvonne · CIK 0001810930 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-06-18

F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan).

SEC source: 0001411690-24-000032 · wk-form4_1718914944.xml · derivative · entry 1

Mamuszka Hannah · CIK 0001810929 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-06-18

F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan).

SEC source: 0001411690-24-000037 · wk-form4_1718914999.xml · derivative · entry 1

Rajkovic Aleksandar · CIK 0001909592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-06-18

F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan).

SEC source: 0001411690-24-000036 · wk-form4_1718914987.xml · derivative · entry 1

Luderer Albert · CIK 0001746822 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-06-18

F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan).

SEC source: 0001411690-24-000035 · wk-form4_1718914977.xml · derivative · entry 1

Vuori Kristiina MD · CIK 0001612627 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-06-18

F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan).

SEC source: 0001411690-24-000034 · wk-form4_1718914965.xml · derivative · entry 1

BARKER DAVID L · CIK 0001189124 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-06-18

F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan).

SEC source: 0001411690-24-000031 · wk-form4_1718914933.xml · derivative · entry 1

TWOMEY CHRISTOPHER J · CIK 0001238935 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-06-18

F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan).

SEC source: 0001415889-24-015624 · form4-06052024_090633.xml · derivative · entry 2

OLDAKOWSKI MARK · CIK 0001745566 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2034-06-02

F4 · derivative.exercise_date: The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of June 3, 2024 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date.

SEC source: 0001415889-24-015624 · form4-06052024_090633.xml · nonDerivative · entry 1

OLDAKOWSKI MARK · CIK 0001745566 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,698

F1 · shares: Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan.

F2 · shares: The shares subject to the RSUs vest 1/4th annually beginning on the one-year anniversary of the grant date.

F3 · balance_after: Includes 54 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "ESPP") on June 9, 2023.

SEC source: 0001415889-24-015622 · form4-06052024_090604.xml · derivative · entry 2

Kama Gulsen · CIK 0001991106 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2034-06-02

F3 · derivative.exercise_date: The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of June 3, 2024 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date.

SEC source: 0001415889-24-015622 · form4-06052024_090604.xml · nonDerivative · entry 1

Kama Gulsen · CIK 0001991106 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,000

F1 · shares: Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan.

F2 · shares: The shares subject to the RSUs vest 1/4th annually beginning on the one-year anniversary of the grant date.

SEC source: 0001415889-24-015621 · form4-06052024_090635.xml · derivative · entry 3

Holmlin R. Erik · CIK 0001579988 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 204,000

Underlying: Common Stock · 204,000 shares

Expires 2034-06-02

F4 · derivative.exercise_date: The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of June 3, 2024 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date.

SEC source: 0001415889-24-015621 · form4-06052024_090635.xml · nonDerivative · entry 1

Holmlin R. Erik · CIK 0001579988 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 121,813

F1 · shares: Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan.

F2 · shares: The shares subject to the RSUs vest 1/4th annually beginning on the one-year anniversary of the grant date.

F3 · balance_after: Includes 150 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "ESPP") on June 9, 2023.

SEC source: 0001415889-24-015620 · form4-06052024_090600.xml · derivative · entry 2

Dixon Jonathan V. · CIK 0001967837 · GENERAL COUNSEL

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,000

Underlying: Common Stock · 68,000 shares

Expires 2034-06-02

F3 · derivative.exercise_date: The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of June 3, 2024 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date.

SEC source: 0001415889-24-015620 · form4-06052024_090600.xml · nonDerivative · entry 1

Dixon Jonathan V. · CIK 0001967837 · GENERAL COUNSEL

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,025

F1 · shares: Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan.

F2 · shares: The shares subject to the RSUs vest 1/4th annually beginning on the one-year anniversary of the grant date.

SEC source: 0001415889-24-015619 · form4-06052024_090611.xml · derivative · entry 2

Chaubey Alka · CIK 0001821605 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2034-06-02

F4 · derivative.exercise_date: The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of June 3, 2024 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date.

SEC source: 0001415889-24-015619 · form4-06052024_090611.xml · nonDerivative · entry 1

Chaubey Alka · CIK 0001821605 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,245

F1 · shares: Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan.

F2 · shares: The shares subject to the RSUs vest 1/4th annually beginning on the one-year anniversary of the grant date.

F3 · balance_after: Includes 150 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "ESPP") on June 9, 2023 and 608 shares acquired under the ESPP from previous years.

SEC source: 0001415889-24-006811 · form4-03052024_100328.xml · nonDerivative · entry 1

Chaubey Alka · CIK 0001821605 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,487

F1 · kind: The reporting person is reporting the withholding by the Issuer of an aggregate of 1,081 shares of common stock in connection with shares that vested on February 15, 2024 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.

F1 · shares: The reporting person is reporting the withholding by the Issuer of an aggregate of 1,081 shares of common stock in connection with shares that vested on February 15, 2024 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.

F2 · balance_after: On August 4, 2023, the common stock of Bionano Genomics, Inc. split 1-for-10, resulting in the reporting person's ownership of 112,315 less shares of common stock.

F3 · balance_after: Includes 89 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan on June 12, 2023.

SEC source: 0001415889-24-006810 · form4-03052024_100327.xml · nonDerivative · entry 1

OLDAKOWSKI MARK · CIK 0001745566 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,644

F1 · kind: The reporting person is reporting the withholding by the Issuer of an aggregate of 1,229 shares of common stock in connection with shares that vested on February 15, 2024 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.

F1 · shares: The reporting person is reporting the withholding by the Issuer of an aggregate of 1,229 shares of common stock in connection with shares that vested on February 15, 2024 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.

F2 · balance_after: On August 4, 2023, the common stock of Bionano Genomics, Inc. split 1-for-10, resulting in the reporting person's ownership of 268,058 less shares of common stock.

F3 · balance_after: Includes 89 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan on June 12, 2023.

SEC source: 0001415889-24-006809 · form4-03052024_100317.xml · nonDerivative · entry 1

Holmlin R. Erik · CIK 0001579988 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,663

F1 · kind: The reporting person is reporting the withholding by the Issuer of an aggregate of 3,073 shares of common stock in connection with shares that vested on February 15, 2024 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.

F1 · shares: The reporting person is reporting the withholding by the Issuer of an aggregate of 3,073 shares of common stock in connection with shares that vested on February 15, 2024 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.

F2 · balance_after: On August 4, 2023, the common stock of Bionano Genomics, Inc. split 1-for-10, resulting in the reporting person's ownership of 730,350 less shares of common stock (725,827 less shares held directly and 4,523 less shares held indirectly).

F3 · balance_after: Includes 89 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan on June 12, 2023.

SEC source: 0001415889-24-006808 · form4-03052024_100330.xml · nonDerivative · entry 1

Dixon Jonathan V. · CIK 0001967837 · GENERAL COUNSEL

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,525

F1 · kind: The reporting person is reporting the withholding by the Issuer of an aggregate of 402 shares of common stock in connection with shares that vested on February 15, 2024 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.

F1 · shares: The reporting person is reporting the withholding by the Issuer of an aggregate of 402 shares of common stock in connection with shares that vested on February 15, 2024 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.

F2 · balance_after: On August 4, 2023, the common stock of Bionano Genomics, Inc. split 1-for-10, resulting in the reporting person's ownership of 35,343 less shares of common stock.

SEC source: 0001209191-23-050186 · doc4.xml · derivative · entry 2

OLDAKOWSKI MARK · CIK 0001745566 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2033-09-17

F2 · derivative.exercise_date: The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of September 11, 2023 (the "Vesting Commencement Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Vesting Commencement Date.

SEC source: 0001209191-23-050186 · doc4.xml · nonDerivative · entry 1

OLDAKOWSKI MARK · CIK 0001745566 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 317,842

F1 · shares: Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan.

SEC source: 0001209191-23-050185 · doc4.xml · derivative · entry 2

Chaubey Alka · CIK 0001821605 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2033-09-17

F2 · derivative.exercise_date: The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of September 11, 2023 (the "Vesting Commencement Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Vesting Commencement Date.

SEC source: 0001209191-23-050185 · doc4.xml · nonDerivative · entry 1

Chaubey Alka · CIK 0001821605 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,794

F1 · shares: Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan.

SEC source: 0001209191-23-050184 · doc4.xml · derivative · entry 1

Kama Gulsen · CIK 0001991106 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,000

Underlying: Common Stock · 106,000 shares

Expires 2033-09-18

F1 · derivative.exercise_date: 25% of the shares subject to the option shall vest and become exercisable on September 11, 2024, and the remaining shares shall vest in a series of 36 successive equal monthly installments measured from September 11, 2024, subject to Reporting Person's Continuous Service (as defined in the Company's 2020 Inducement Plan, as amended) through each such applicable vesting date and the terms of the Company's 2020 Inducement Plan, as amended.

SEC source: 0001411690-23-000054 · wf-form4_168694650593900.xml · derivative · entry 1

Wong Vincent Jung-Fai · CIK 0001898723 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2033-06-14

F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan).

SEC source: 0001411690-23-000055 · wf-form4_168694654303458.xml · derivative · entry 1

Linney Yvonne · CIK 0001810930 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2033-06-14

F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan).

SEC source: 0001411690-23-000058 · wf-form4_168694661088294.xml · derivative · entry 1

Mamuszka Hannah · CIK 0001810929 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2033-06-14

F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan).

SEC source: 0001411690-23-000057 · wf-form4_168694659605901.xml · derivative · entry 1

Rajkovic Aleksandar · CIK 0001909592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2033-06-14

F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan).

SEC source: 0001411690-23-000056 · wf-form4_168694656876329.xml · derivative · entry 1

Luderer Albert · CIK 0001746822 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2033-06-14

F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan).

SEC source: 0001411690-23-000053 · wf-form4_168694648962541.xml · derivative · entry 1

Vuori Kristiina MD · CIK 0001612627 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2033-06-14

F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan).

SEC source: 0001411690-23-000052 · wf-form4_168694647426200.xml · derivative · entry 1

TWOMEY CHRISTOPHER J · CIK 0001238935 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2033-06-14

F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan).

SEC source: 0001411690-23-000051 · wf-form4_168694646055716.xml · derivative · entry 1

BARKER DAVID L · CIK 0001189124 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2033-06-14

F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan).

SEC source: 0001411690-23-000034 · wf-form4_168678194063640.xml · nonDerivative · entry 1

Mamuszka Hannah · CIK 0001810929 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,789

SEC source: 0001411690-23-000032 · wf-form4_168427581326105.xml · nonDerivative · entry 1

Holmlin R. Erik · CIK 0001579988 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 806,474

F1 · price: The price reported in Column 4 is the weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.64160 to $0.643099, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.

SEC source: 0001411690-23-000031 · wf-form4_168427572747814.xml · nonDerivative · entry 1

Stewart Christopher P. · CIK 0001822991 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 281,373

F1 · price: The price reported in Column 4 is the weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6682 to $0.6683, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.

SEC source: 0001411690-23-000029 · wf-form4_168427549067289.xml · nonDerivative · entry 1

Holmlin R. Erik · CIK 0001579988 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 791,474

F1 · kind: The reporting person is reporting the withholding by the Issuer of an aggregate of 50,141 shares of common stock that vested on May 12, 2023 pursuant to an RSU award granted on May 12, 2021, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.

SEC source: 0001411690-23-000030 · wf-form4_168427559071904.xml · nonDerivative · entry 1

OLDAKOWSKI MARK · CIK 0001745566 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 297,842

F1 · kind: The reporting person is reporting the withholding by the Issuer of an aggregate of 41,496 shares of common stock that vested on May 12, 2023 pursuant to an RSU award granted on May 12, 2021, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.

SEC source: 0001209191-23-010921 · doc4.xml · derivative · entry 3

Holmlin R. Erik · CIK 0001579988 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,400,000

Underlying: Common Stock · 1,400,000 shares

Expires 2033-02-14

F3 · derivative.exercise_date: The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 15, 2023 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date.

SEC source: 0001209191-23-010921 · doc4.xml · nonDerivative · entry 1

Holmlin R. Erik · CIK 0001579988 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 841,615

F1 · shares: Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan.

F2 · balance_after: Includes 1,443 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "ESPP") on June 10, 2022 and 1,616 shares acquired under the ESPP on December 10, 2022.

SEC source: 0001209191-23-010920 · doc4.xml · derivative · entry 2

OLDAKOWSKI MARK · CIK 0001745566 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 560,000

Underlying: Common Stock · 560,000 shares

Expires 2033-02-14

F3 · derivative.exercise_date: The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 15, 2023 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date.

SEC source: 0001209191-23-010920 · doc4.xml · nonDerivative · entry 1

OLDAKOWSKI MARK · CIK 0001745566 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 339,338

F1 · shares: Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan.

F2 · balance_after: Includes 1,424 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "ESPP") on June 10, 2022 and 1,245 shares acquired under the ESPP on December 10, 2022.

SEC source: 0001209191-23-010919 · doc4.xml · derivative · entry 2

Chaubey Alka · CIK 0001821605 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 560,000

Underlying: Common Stock · 560,000 shares

Expires 2033-02-14

F3 · derivative.exercise_date: The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 15, 2023 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date.

SEC source: 0001209191-23-010919 · doc4.xml · nonDerivative · entry 1

Chaubey Alka · CIK 0001821605 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,794

F1 · shares: Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan.

F2 · balance_after: Includes 2,285 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "ESPP") on June 10, 2022 and 2,509 shares acquired under the ESPP on December 10, 2022.